Related by context. All words. (Click for frequent words.) 80 plus ribavirin 79 peginterferon 76 ribavirin 76 pegylated interferon alpha 76 peginterferon alfa 2a 76 peg IFN 74 ribavirin RBV 73 dacarbazine 73 Peg IFN 73 peginterferon alfa 2b 73 ribavirin therapy 72 pegylated interferon alfa 2a 71 lamivudine 71 Pegasys ® 71 docetaxel 70 PegIFN RBV 70 HCV genotype 1 70 pegylated interferon alfa 70 Pegasys plus Copegus 70 nitazoxanide 69 peg interferon 69 alfa 2a 69 telaprevir dosed 69 FOLFIRI 68 Fludara 68 viral kinetics 68 FOLFOX 68 sustained virologic response 68 TMC# [001] 68 APTIVUS r 68 docetaxel chemotherapy 68 decitabine 68 active comparator 68 interferon alfa 2a 68 plus dexamethasone 68 Taxotere ® 68 REBETOL 67 interferon alfa 2b 67 PEGINTRON 67 lopinavir r 67 Copegus ribavirin 67 LEXIVA r 67 PegIntron 67 monotherapy 67 sunitinib 67 ritonavir boosted 67 PREZISTA r 66 CIMZIA TM 66 topotecan 66 DMARDs 66 capecitabine 66 irinotecan 66 interferon alfa 66 pegylated interferon alfa 2b 66 Ribavirin 66 rituximab 66 adalimumab 66 COPEGUS 66 azacitidine 66 APTIVUS 66 carboplatin paclitaxel 66 pegylated interferon peg IFN 66 virologic failure 66 telaprevir 66 valopicitabine 66 abacavir lamivudine 66 ACTEMRA TM 65 PEG interferon 65 sustained virological response 65 Pegasys peginterferon alfa 2a 65 INTELENCE 65 gemcitabine 65 TNF inhibitor 65 anti TNF 65 adefovir 65 protease inhibitor PI 65 azathioprine 65 Peginterferon 65 peginterferon alfa 2a #KD 65 fluconazole 65 infliximab 65 5-FU/LV 65 NNRTI 65 interferon 65 Pegasys 65 Aptivus ® 65 mapatumumab 65 entecavir 65 tipranavir 65 achieve sustained virologic 65 ISENTRESS 65 interferon ribavirin 65 VICTRELIS 65 raltegravir 65 DOXIL 65 chlorambucil 65 interferon therapy 65 tenofovir emtricitabine 65 bendamustine 65 pegylated interferon alpha 2a 65 COMBIVIR 65 nab paclitaxel 64 LPV r 64 sorafenib 64 Traficet EN 64 interferon alpha 64 peginterferon alfa 64 cytarabine 64 Copegus 64 trastuzumab 64 docetaxel Taxotere ® 64 HCV RESPOND 2 64 fludarabine 64 carboplatin 64 metastatic renal cell carcinoma 64 ABC/3TC 64 posaconazole 64 achieved sustained virologic 64 mitoxantrone 64 undetectable HCV RNA 64 Pegasys R 64 plus prednisone 64 TYKERB 64 sorafenib Nexavar 64 mRCC 64 lopinavir ritonavir 64 vinorelbine 64 bevacizumab 64 PEG Intron 64 methotrexate MTX 64 clodronate 64 #mg QD [002] 64 dexamethasone 64 temozolomide 64 idarubicin 64 relapsed MM 64 chronic hepatitis C 64 disease modifying antirheumatic 64 pegylated alpha interferon 63 placebo dexamethasone 63 3TC lamivudine Epivir 63 tenofovir disoproxil fumarate 63 null responders 63 standard chemotherapy regimen 63 low dose cytarabine 63 amoxicillin clavulanate 63 boosted protease inhibitor 63 administered subcutaneously 63 trabectedin 63 dasatinib 63 pomalidomide 63 COPEGUS ribavirin 63 Hepsera 63 plus COPEGUS 63 alpha 2b 63 CANCIDAS 63 FOLFOX4 63 PEGINTRON TM 63 virologic response 63 TDF FTC 63 SCH # 63 PegIFN 63 celgosivir 63 boceprevir 63 bortezomib 63 tocilizumab 63 voriconazole 63 virological failure 63 adalimumab Humira 63 leucovorin 63 chemotherapy regimens 63 CHOP chemotherapy 63 linezolid 63 cetuximab 63 mcg dose 63 alpha 2a 63 imatinib 63 fluticasone 63 protease inhibitor 63 infusional 5-FU/LV 63 VELCADE melphalan 63 8mg/kg 63 oral rivaroxaban 63 Copegus ® ribavirin 63 oral allopurinol 63 mg QD 63 isoniazid 63 mcg kg 62 anthracycline taxane 62 tinidazole 62 Xeloda 62 lenalidomide Revlimid R 62 metastatic RCC 62 mcg albinterferon alfa 2b 62 darunavir ritonavir 62 HBeAg positive 62 pegylated interferons 62 Viramidine 62 Rebetol 62 chronic HCV infection 62 abatacept 62 Taxotere 62 NRTI 62 Doxil ® 62 imipenem 62 erlotinib 62 q8h 62 peginterferon alpha 2a 62 5 fluorouracil 62 Peginterferon alfa 2a 62 darunavir 62 CAELYX 62 mg BID 62 NRTIs 62 estramustine 62 cisplatin 62 ritonavir boosted atazanavir 62 DAPT 62 Raptiva r 62 daunorubicin 62 advanced NSCLC 62 VIRAMUNE 62 HCV SPRINT 62 biologic DMARD 62 PREZISTA ritonavir 62 PEGASYS ® 62 PREZISTA 62 DMARD 62 nilotinib 62 pegylated liposomal doxorubicin 62 CIMZIA ™ 62 Pegylated Interferon 62 lapatinib 62 PEG INTRON 62 gemcitabine carboplatin 62 dexamethasone Decadron 62 chemoradiation 62 pegylated 62 mg RDEA# 62 5FU 62 temsirolimus 62 amprenavir 62 dose regimen 62 AZT zidovudine Retrovir 62 dose cytarabine 62 mg kg dose 62 pyrazinamide 62 uric acid lowering 62 Darunavir 62 Peginterferon Alfa 2a 62 stavudine d4T 62 VFEND 62 vancomycin 62 panitumumab 62 Taxotere R 62 efavirenz EFV 61 Herceptin trastuzumab 61 randomized #:# 61 docetaxel Taxotere R 61 doxorubicin HCl liposome injection 61 chemotherapy regimen 61 amodiaquine 61 FluCAM 61 LEXIVA 61 dosing cohorts 61 Virologic 61 R# #mg BID 61 irinotecan chemotherapy 61 subcutaneously administered 61 fosamprenavir 61 OncoVEX GM CSF 61 achieved sustained virological 61 plus gemcitabine 61 REYATAZ r 61 mg dose 61 atazanavir ritonavir 61 anti rheumatic 61 allopurinol 61 fluticasone salmeterol 61 naïve HCV 61 sorafenib Nexavar ® 61 FOLFOX6 61 APTIVUS ritonavir 61 vicriviroc 61 goserelin 61 etanercept 61 BARACLUDE ® 61 Jevtana 61 lenalidomide 61 hepatitis C genotype 61 Epivir 61 REMICADE ® 61 zidovudine lamivudine 61 SVR# 61 SYMBICORT 61 #mg/m# [002] 61 cytotoxic therapy 61 octreotide LAR 61 standard chemotherapy regimens 61 paclitaxel Taxol 61 pemetrexed 61 methotrexate 61 mycophenolate mofetil 61 HCV infected 61 Anti TNF 61 tiotropium 61 romiplostim 61 Gemcitabine 61 lamivudine 3TC 61 Tipranavir 61 telbivudine 61 fluorouracil 61 TNF inhibitors 61 bevacizumab Avastin 61 rilpivirine 61 lopinavir 61 anti TNF alpha 61 XGEVA 61 peginterferon alfa 2a Pegasys 61 biologic therapy 61 evaluating tivozanib 61 cetuximab Erbitux ® 61 Elitek 61 cyclophosphamide 61 #mg/m# [001] 61 zidovudine AZT 61 ceftazidime 61 virological response 61 doxorubicin docetaxel 61 dose cohorts 61 gemcitabine Gemzar 61 oral vancomycin 61 ethambutol 61 REYATAZ R 61 Torisel 61 EPZICOM 61 Pegintron 61 tipranavir ritonavir 61 dose regimens 61 maraviroc 61 Irinotecan 61 ceftriaxone 61 cetuximab Erbitux R 61 dasatinib Sprycel ® 61 darunavir r 61 LMWH 61 anakinra 61 NRTI backbone 61 Trastuzumab 61 q#h 60 detectable HCV RNA 60 paclitaxel carboplatin 60 methotrexate therapy 60 μg dose 60 chronic HCV 60 Allovectin 7 ® 60 certolizumab 60 tamoxifen therapy 60 VIDAZA 60 ZOLINZA 60 achieved ACR# 60 oxaliplatin 60 vandetanib 60 relapsed multiple myeloma 60 NOXAFIL 60 efavirenz 60 trastuzumab Herceptin R 60 gefitinib 60 taxane chemotherapy 60 clopidogrel 60 antiretroviral regimen 60 enfuvirtide 60 atazanavir 60 chemotherapy gemcitabine 60 EGFR expressing mCRC 60 DMARD therapy 60 SCIg 60 docetaxel Taxotere 60 telaprevir VX 60 bevirimat 60 XELOX 60 amphotericin B 60 TRIZIVIR 60 rizatriptan 60 ELOXATIN 60 glatiramer acetate 60 INVANZ 60 erlotinib Tarceva ® 60 #mg QD [001] 60 antiretroviral naive 60 tenofovir DF 60 HCV 60 pertuzumab 60 etravirine 60 saline placebo 60 ritonavir 60 cEVR 60 levofloxacin 60 NNRTIs 60 FROVA 60 FASLODEX 60 aflibercept 60 Cladribine tablets 60 tenofovir Viread 60 virologic 60 Certolizumab 60 metronidazole 60 gemcitabine chemotherapy 60 IV bolus 60 PEG Interferon alfa 60 febuxostat 60 plus methotrexate 60 amrubicin 60 Sandostatin LAR Depot 60 relapsed CLL 60 PEG IFN 60 chronic ITP patients 60 moxifloxacin 60 receiving VICTRELIS 60 lamivudine monotherapy 60 Combivir 60 efavirenz Sustiva 60 refractory CLL 60 infliximab monotherapy 60 TORISEL 60 NATRECOR ® 60 PEG INTRON R 60 antiretroviral therapy 60 trastuzumab Herceptin ® 60 Hycamtin ® 60 TNF antagonist 60 recurrent genital herpes 60 telaprevir dosing 60 Sandostatin LAR 60 REVLIMID ® 60 PROMACTA 60 Elvitegravir 60 HAART regimens 60 HBeAg positive patients 60 lesinurad 60 antiretroviral regimens 60 recurrent GBM 60 co trimoxazole 60 Navelbine ® 60 AZILECT R 60 interferon gamma 1b 60 null responder HCV 60 transcriptase inhibitor NNRTI 60 salmeterol fluticasone 60 gemcitabine cisplatin 60 forodesine 60 #mg BID [001] 60 metastatic hormone refractory 59 Tarceva TM 59 divalproex sodium 59 rapid virologic response 59 cART 59 abiraterone acetate 59 log# reduction 59 TMC# r 59 doripenem 59 Velcade bortezomib 59 ZYVOX 59 dosage regimens 59 refractory NSCLC 59 Cethromycin 59 virus HCV protease inhibitor 59 oral levofloxacin 59 undetectable viral load 59 Lamivudine 59 nucleoside analog 59 naive HCV 59 ketoconazole 59 intravenous bisphosphonates 59 pegfilgrastim 59 Alkeran 59 #mg q8h 59 nevirapine Viramune 59 TNF antagonists 59 Boceprevir 59 ascending doses 59 imatinib therapy 59 daily Infergen 59 ARIKACE 59 Lenalidomide 59 refractory AML 59 plus prednisone prednisolone 59 oral ridaforolimus 59 IFN alfa 59 IRESSA 59 albinterferon alfa 2b 59 induction regimen 59 cidofovir 59 chemoradiotherapy 59 ibandronate 59 ritonavir boosted lopinavir 59 Capecitabine 59 PREZISTA rtv 59 docetaxel prednisone 59 EGFR TKI 59 dosing intervals 59 idraparinux 59 pegylated interferon ribavirin 59 potent CYP#A# inhibitors 59 eltrombopag 59 #mg BID [003] 59 MabCampath 59 invasive candidiasis 59 alkylating agent 59 Topotecan 59 treatment naïve genotype 59 neurologic progression 59 relapsed refractory multiple myeloma 59 mg qd 59 VIRAMUNE XR 59 Gemzar ® 59 paclitaxel Taxol R 59 valacyclovir 59 irbesartan 59 tigecycline 59 piperacillin tazobactam 59 fluoropyrimidine 59 maximally tolerated dose 59 HGS ETR1 59 viral suppression 59 hepatitis C virus 59 MIRCERA 59 FOLFOX chemotherapy 59 Amrubicin 59 peginterferon ribavirin 59 HGS# 59 zolmitriptan 59 immunomodulator 59 treatment regimens 59 treatment naive genotype 59 RG# [001] 59 HuMax CD4 59 paclitaxel 59 Clevudine 59 steroid dexamethasone 59 pyridostigmine 59 nucleoside analogue 59 rifapentine 59 Pemetrexed 59 free survival PFS 59 Adalimumab 59 sorafenib tablets 59 indacaterol 59 ustekinumab 59 TACE 59 efalizumab 59 Dacogen 59 Hepsera adefovir dipivoxil 59 Telaprevir 59 beta2 agonist 59 Flu Cy 59 Telbivudine 59 mg/m2 dose 59 pegIFN 59 iniparib 59 serum phosphorus 59 relapsed myeloma 59 paclitaxel Taxol ® 59 suppressive therapy 59 adriamycin 59 Pegylated interferon 59 CCR5 tropic HIV 59 RGT arm 59 5 FU leucovorin 59 rilonacept 59 chemotherapies 59 ixabepilone 59 zidovudine 59 tirofiban 59 subcutaneous injections 59 Lupuzor ™ 59 heavily pretreated 59 dose dexamethasone 59 saquinavir 59 ribavirin USP 59 Actilon 59 metastatic CRC 59 TEMODAL 59 5 FU 58 #mg/day [002] 58 BARACLUDE R 58 Xcytrin 58 telaprevir pegylated interferon 58 bosentan 58 4mg/kg 58 Folfox 58 mCRC patients 58 DEB# 58 indinavir 58 montelukast 58 median PFS 58 methotrexate monotherapy 58 weekly subcutaneous injections 58 oral diclofenac 58 chemotherapeutic regimens 58 HCV RNA 58 AVELOX 58 Vectibix 58 Revlimid lenalidomide 58 symptomatic BPH 58 tolvaptan 58 clopidogrel Plavix 58 #mg dose [001] 58 alefacept 58 omega interferon 58 antiviral activity 58 bicalutamide 58 diagnosed multiple myeloma 58 lumiliximab 58 ULORIC 58 baminercept 58 evaluable patients 58 TMC# C# 58 low dose ritonavir 58 Aflibercept 58 neoadjuvant chemotherapy 58 metastatic SCCHN 58 ARB telmisartan 58 lopinavir ritonavir Kaletra 58 unresectable stage 58 adefovir dipivoxil 58 alfa 2b 58 tamsulosin 58 micafungin 58 sorafenib Nexavar R 58 Tarceva erlotinib 58 paliperidone ER 58 pioglitazone 58 metformin HCl 58 CR nPR 58 Cytoxan 58 degarelix 58 Fludara ® 58 ritonavir boosted protease inhibitor 58 TYGACIL 58 Tamibarotene 58 metastatic castration resistant 58 bevacizumab Avastin ® 58 sulfadoxine pyrimethamine 58 HBeAg seroconversion 58 inhaled corticosteroids 58 antiviral therapy 58 Mylotarg 58 basal insulin 58 PEG Intron ® 58 SPRYCEL ® 58 Engerix B 58 KRAS mutations occur 58 cytotoxic chemotherapy 58 Imprime PGG 58 VELCADE 58 anthracycline containing 58 virologically 58 ertapenem 58 relapsed ovarian cancer 58 Phase 2b study 58 AGILECT R 58 lamivudine zidovudine 58 JANUVIA 58 dose cohort 58 CoFactor 58 cisplatin chemotherapy 58 evaluable 58 Roche Pegasys 58 melphalan prednisone 58 nucleoside analogues 58 Dasatinib 58 placebo 58 lapatinib Tykerb 58 BEACOPP 58 leukotriene receptor antagonist 58 Vidaza 58 pegylated liposomal doxorubicin PLD 58 comparator PI r 58 Elotuzumab 58 ACTEMRA 58 nonresponders 58 eribulin 58 LY# [003] 58 angiotensin receptor blocker ARB 58 ARIXTRA 58 APTIVUS R 58 dacarbazine DTIC 58 relapsers 58 eptifibatide 58 DU #b 58 FIRMAGON 58 etoposide 58 mcg doses 58 dosing regimens 58 mg ustekinumab 58 KAPIDEX 58 placebo intravenously 58 refractory multiple myeloma 58 visilizumab 58 Valcyte 58 TMP SMX 58 randomized Phase III 58 benazepril 58 Aptivus 58 Copegus ® 58 splenectomized patients 58 integrase inhibitor 58 metastatic GIST 58 lopinavir r arm 58 cisplatin gemcitabine 58 sulfonylurea 58 Platinol ® cisplatin 58 antithrombotics 58 AMEVIVE 58 elagolix 58 oral anticoagulant 58 FUZEON 58 oxycodone CR 58 STELARA 58 xanthine oxidase inhibitor 58 pemetrexed Alimta 58 nelfinavir 58 BARACLUDE 58 Lopinavir ritonavir 58 TAXOTERE R 58 nucleoside reverse transcriptase inhibitors 58 chronic HCV genotype 58 serum HCV RNA 58 sulphonylurea 58 unfractionated heparin 58 zalutumumab 58 canakinumab 58 unresectable 58 NXL# 58 Selzentry 58 infliximab therapy 58 Platinol ® 58 temsirolimus Torisel ® 58 enalapril 58 invasive aspergillosis 58 dose dose escalation 58 HCV genotype 58 Copegus R 58 neoadjuvant 58 #mg dose [003] 58 tolterodine 58 metformin 58 hepatitis C HCV 58 Paraplatin ® 58 Xeloda ® 58 Interferon alpha 58 Q2W 58 dalteparin 58 gout flares 58 chemotherapy docetaxel 58 #mg doses [002] 58 Trizivir 58 Peginterferon alfa 2b 58 sunitinib malate 58 nevirapine NVP 58 HCV infection 58 beclomethasone dipropionate 58 EPIVIR 58 Amigal 58 oral FTY# 58 ALVESCO 58 SPRYCEL 58 ZIAGEN 58 nucleotide analogue 58 OADs 58 PRT# 58 dacarbazine chemotherapy 58 Perforomist Inhalation Solution 58 tiotropium bromide 57 cabazitaxel 57 randomized 57 comparator arm 57 thymalfasin 57 HBV DNA 57 tyrosine kinase inhibitor TKI 57 adult chronic ITP 57 tolerability 57 Bevacizumab 57 IIIa inhibitor 57 Lamictal XR 57 ORENCIA ® 57 teriflunomide 57 metastatic colorectal cancer 57 YONDELIS 57 ACR# response 57 bisphosphonate therapy 57 VPRIV 57 ONGLYZA 57 REBETOL combination therapy 57 stavudine 57 Epivir HBV 57 remission induction 57 microbiological eradication 57 TELINTRA 57 aliskiren 57 Gleevec imatinib 57 Eloxatin R 57 INTEGRILIN R 57 anthracycline 57 Viread Emtriva 57 Pfizer Sutent 57 capecitabine Xeloda 57 caspofungin 57 flutamide 57 stage IIIB 57 mg TID 57 cangrelor 57 DOXIL ® 57 DORIBAX 57 relapsed SCLC 57 doxorubicin cyclophosphamide 57 immunosuppressant 57 cell lymphoma CTCL 57 salmeterol 57 cyclophosphamide methotrexate 57 polymerase inhibitor 57 Moxifloxacin 57 RoACTEMRA 57 folinic acid 57 inhaled corticosteroid ICS 57 CML CP 57 trimethoprim sulfamethoxazole 57 panitumumab Vectibix 57 Peg Intron 57 Free Survival PFS 57 mitomycin 57 antiviral efficacy 57 plus MTX 57 zoledronic acid 57 administered intravenously 57 intravenous cyclophosphamide 57 Interferon alfa 57 tipranavir r 57 Nitazoxanide 57 undetectable virus HCV 57 #mg/kg [002] 57 INFERGEN 57 CCyR 57 irinotecan containing 57 ABRAXANE therapy 57 viral load 57 colesevelam HCl 57 lenalidomide dexamethasone 57 sirolimus eluting stent 57 doxorubicin 57 IU mL 57 inhaled steroid 57 REVLIMID lenalidomide 57 cyclophosphamide doxorubicin vincristine 57 velafermin 57 phase IIb clinical 57 Helicobacter pylori eradication 57 oral antiviral 57 potentially hepatotoxic 57 pazopanib 57 elotuzumab 57 Incivek 57 non squamous NSCLC 57 olmesartan 57 QVA# 57 oral ribavirin 57 antiretroviral therapy ART 57 Cloretazine 57 HBeAg negative 57 YERVOY 57 Chronic Hepatitis C 57 itraconazole 57 miconazole 57 chronic angina 57 Dacogen injection 57 Xelox 57 #mg/#mg 57 rt PA 57 octreotide 57 G CSF 57 KETEK 57 taxane 57 Alinia 57 mg/m2 57 Rituxan 57 antiretroviral naïve 57 relapsing MS 57 mg subcutaneously 57 protease inhibitors PIs 57 FOSRENOL R 57 adjunctive placebo 57 ANA# 57 subcutaneous formulation 57 Camptosar ® 57 dasatinib Sprycel 57 RRMS patients 57 low dose dexamethasone 57 metformin sulfonylurea 57 bexarotene 57 timolol 57 progression TTP 57 immunosuppressive agents 57 budesonide 57 paclitaxel chemotherapy 57 oral Xeloda 57 CRp 57 Seliciclib 57 oxaliplatin Eloxatin 57 Reverset 57 alteplase 57 amiodarone 57 mometasone 57 thalidomide Thalomid 57 dapsone 57 continuous intravenous infusion 57 AZILECT 57 non nucleoside reverse 57 nucleotide analog 57 FOLFIRI alone 57 rivaroxaban 57 Erlotinib 57 primary hypercholesterolemia 57 pharmacologically active isomer 57 FOSRENOL ® 57 levosimendan 57 ATACAND 57 achieved PASI 57 CA4P 57 Doxil 57 undetectable viral loads 57 evaluable subjects 57 dabigatran etexilate 57 tenofovir 57 heavily pretreated patients 57 Kepivance 57 prior chemotherapy regimens 57 chronic hepatitis B. 57 alpha interferon 57 Noxafil 57 axitinib 57 concurrent chemoradiation 57 lamivudine refractory patients 57 nucleoside naive 57 mg/m2 administered 57 receiving INTRON 57 carbidopa levodopa 57 fluvastatin 57 Pazopanib 57 BROVANA 57 Xanafide 57 CCR5 antagonist 57 angiotensin converting enzyme inhibitors 57 ascending dose 57 TKI therapy 57 riociguat 57 HER2 positive metastatic breast 57 5 fluorouracil leucovorin 57 seroconversion 57 ganciclovir 57 blinded randomized placebo controlled 57 recurrent NSCLC 57 oblimersen 57 tacrolimus ointment 57 PASI scores 57 NVA# 57 ARIMIDEX 57 intravitreal injection 57 therapeutic regimens 57 cytarabine daunorubicin 57 Velcade 57 Rifampin 57 Vertex telaprevir 57 atazanavir Reyataz 57 pancreatic NET 57 prostate cancer HRPC 57 mg/m2 IV 57 aspirin heparin 57 BAY #-# 57 elvitegravir 57 HCV genotypes 56 paliperidone palmitate 56 FOLFOX6 chemotherapy regimen 56 #mg ritonavir 56 emtricitabine tenofovir 56 melphalan 56 ketorolac 56 Targretin 56 EFAPROXYN 56 COPAXONE R 56 complete cytogenetic 56 ribavirin Copegus 56 sitagliptin 56 #mg BID [002] 56 saquinavir ritonavir 56 REYATAZ ® 56 tyrosine kinase inhibitor 56 SCCHN 56 MAGE A3 ASCI